Latest Breaking News On - Applied pharmaceutical innovation - Page 1 : comparemela.com

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomJoshua bartchDavid coffman george duxberryHealth canadaMydecine innovations groupUniversity of albertaAnalog developmentTrademark officeJohns hopkins universityMydecine innovations group incEuropean union withdrawalCorporate advisornovum securitiesInnovations groupUnited states patent

Mydecine Innovations Group Receives Two Notice of

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG).

British columbiaUnited kingdomUnited statesDavid coffman george duxberryJoshua bartchTrademark officeMydecine innovations group incJohns hopkins universityEuropean union withdrawalMydecine innovations groupHealth canadaUniversity of albertaNovum securitiesAnalog developmentInnovations groupUnited states patent

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

VANCOUVER, British Columbia, Feb. 07, 2024 Mydecine Innovations Group Inc. , a leading biotechnology company dedicated to transforming mental health and addiction treatment, proudly.

United kingdomBritish columbiaUnited statesJoshua bartchDavid coffman george duxberryEuropean union withdrawalMydecine innovations group incJohns hopkins universityTrademark officeAnalog developmentNovum securitiesUniversity of albertaHealth canadaMydecine innovations groupInnovations groupUnited states patent

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaJoshua bartchDavid coffman george duxberryEuropean union withdrawalMydecine innovations groupTrademark officeNovum securitiesJohns hopkins universityMydecine innovations group incHealth canadaAnalog developmentUniversity of albertaInnovations groupUnited states patent

Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 Mydecine Innovations Group Inc. , a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment, announces.

British columbiaUnited kingdomUnited statesJoshua bartchNeil stevenson mooreDavid coffman george duxberryMydecine innovations group incHealth canadaMydecine innovations groupUniversity of albertaNovum securitiesEuropean union withdrawalJohns hopkins universityInnovations groupMarket abuse regulationEuropean union